Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Long-acting β2-agonist step-off in patients with controlled asthma.

Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, Santesso N, Strunk RC, Casale TB.

Arch Intern Med. 2012 Oct 8;172(18):1365-75. Review.

PMID:
22928176
2.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
3.
4.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
5.

Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.

Ahmad S, Kew KM, Normansell R.

Cochrane Database Syst Rev. 2015 Jun 19;(6):CD011306. doi: 10.1002/14651858.CD011306.pub2. Review.

PMID:
26089258
6.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003137. doi: 10.1002/14651858.CD003137.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003137.

PMID:
21563136
7.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

8.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137.

PMID:
15674901
9.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

10.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
11.

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.

Kew KM, Evans DJ, Allison DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jun 2;(6):CD011438. doi: 10.1002/14651858.CD011438.pub2. Review.

PMID:
26031392
12.

Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids.

Kew KM, Beggs S, Ahmad S.

Cochrane Database Syst Rev. 2015 May 21;(5):CD011316. doi: 10.1002/14651858.CD011316.pub2. Review.

PMID:
25997166
13.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Chauhan BF, Ducharme FM.

Cochrane Database Syst Rev. 2014 Jan 24;(1):CD003137. doi: 10.1002/14651858.CD003137.pub5. Review.

PMID:
24459050
14.

Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.

Gibson PG, Powell H, Ducharme F.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005076. Review.

PMID:
16235393
15.

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

Chung KF, Caramori G, Adcock IM.

Eur J Clin Pharmacol. 2009 Sep;65(9):853-71. doi: 10.1007/s00228-009-0682-z. Epub 2009 Jun 26. Review.

PMID:
19557399
16.

Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis.

Goyal V, Chang AB.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD010327. doi: 10.1002/14651858.CD010327.pub2. Review.

PMID:
24913725
17.

A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma.

Castro-Rodriguez JA, Rodrigo GJ.

Pediatrics. 2012 Sep;130(3):e650-7. doi: 10.1542/peds.2012-0162. Epub 2012 Aug 27. Review.

18.

Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.

Tamm M, Richards DH, Beghé B, Fabbri L.

Respir Med. 2012 Dec;106 Suppl 1:S9-19. doi: 10.1016/S0954-6111(12)70005-7. Review.

19.

The β-2 agonist debate: is there still a problem?

Patel M, Shirtcliffe P, Beasley R.

Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):58-62. doi: 10.1097/ACI.0b013e32835a5ad9. Review.

PMID:
23037719
20.

Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.

Ducharme F, Schwartz Z, Hicks G, Kakuma R.

Cochrane Database Syst Rev. 2004;(2):CD003133. Review.

PMID:
15106191

Supplemental Content

Support Center